The association between ANKH promoter polymorphism and chondrocalcinosis is independent of age and osteoarthritis: Results of a case-control study

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Abhishek, Abhishek ^a,b   Doherty, Sally ^b   Maciewicz, Rose ^c   Muir, Kenneth ^d   Zhang, Weiya ^b   Doherty, Michael ^b   Valdes, Anna M ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANKH PROTEIN, HUMAN; PHOSPHATE TRANSPORTER;

AGE; AGED; CASE CONTROL STUDY; CHONDROCALCINOSIS; COMPLICATION; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; OSTEOARTHRITIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE FACTORS; AGED; CASE-CONTROL STUDIES; CHONDROCALCINOSIS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PHOSPHATE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84893810320     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4453     Document Type: Article

References (32)

1. Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L. European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011, 70:563-570. 10.1136/ard.2010.139105, 21216817.
2. Richette P, Bardin T, Doherty M. An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology (Oxford) 2009, 48:711-715. 10.1093/rheumatology/kep081, 19398486.
3. Abhishek A, Doherty M. Pathophysiology of articular chondrocalcinosis-role of ANKH. Nat Rev Rheumatol 2011, 7:96-104. 10.1038/nrrheum.2010.182, 21102543.
4. Andrew LJ, Brancolini V, de la Pena LS, Devoto M, Caeiro F, Marchegiani R, Reginato A, Gaucher A, Netter P, Gillet P, Loeuille D, Prockop DJ, Carr A, Wordsworth BF, Lathrop M, Butcher S, Considine E, Everts K, Nicod A, Walsh S, Williams CJ. Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease. Am J Hum Genet 1999, 64:136-145. 10.1086/302186, 1377711, 9915952.
5. Béjia I, Rtibi I, Touzi M, Zrour S, Younes M, Naceur B. Familial calcium pyrophosphate dihydrate deposition disease. A Tunisian kindred. Joint Bone Spine 2004, 71:401-408. 10.1016/j.jbspin.2003.10.012, 15474392.
6. Gaudreau A, Camerlain M, Pibarot ML, Beauregard G, Lebrun A, Petitclerc C. Familial articular chondrocalcinosis in Quebec. Arthritis Rheum 1981, 24:611-615. 10.1002/art.1780240407, 7213442.
7. Hamza M, Meddeb N, Bardin T. Hereditary chondrocalcinosis in a Tunisian family. Clin Exp Rheumatol 1992, 10:43-49.
8. Hamza M, Ayed K, Bardi R, Gebuhrer L, Betuel H, Bardin T, Plaetke R, Lathrop M. HLA-antigens in a Tunisian familial chondrocalcinosis. Dis Markers 1990, 8:109-112.
9. Reginato AJ, Hollander JL, Martinez V, Valenzuela F, Schiapachasse V, Covarrubias E, Jacobelli S, Arinoviche R, Silcox D, Ruiz F. Familial chondrocalcinosis in the Chiloe Islands, Chile. Ann Rheum Dis 1975, 34:260-268. 10.1136/ard.34.3.260, 1006409, 168817.
10. Riestra JL, Sanchez A, Rodriguez-Valverde V, Alonso JL, de la Hera M, Merino J. Radiographic features of hereditary articular chondrocalcinosis. A comparative study with the sporadic type. Clin Exp Rheumatol 1988, 6:369-372.
11. Doherty M, Hamilton E, Henderson J, Misra H, Dixey J. Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families. Br J Rheumatol 1991, 30:10-15.
12. Williams CJ, Zhang Y, Timms A, Bonavita G, Caeiro F, Broxholme J, Cuthbertson J, Jones Y, Marchegiani R, Reginato A, Russell RG, Wordsworth BP, Carr AJ, Brown MA. Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. Am J Hum Genet 2002, 71:985-991. 10.1086/343053, 419998, 12297989.
13. Baldwin CT, Farrer LA, Adair R, Dharmavaram R, Jimenez S, Anderson L. Linkage of early-onset osteoarthritis and chondrocalcinosis to human chromosome 8q. Am J Hum Genet 1995, 56:692-697. 1801178, 7887424.
14. Zhang Y, Johnson K, Russell RG, Wordsworth BP, Carr AJ, Terkeltaub RA, Brown MA. Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate. Arthritis Rheum 2005, 52:1110-1117. 10.1002/art.20978, 15818664.
15. Zhang W, Neame R, Doherty S, Doherty M. Relative risk of knee chondrocalcinosis in siblings of index cases with pyrophosphate arthropathy. Ann Rheum Dis 2004, 63:969-973. 10.1136/ard.2003.015206, 1755084, 15249324.
16. Valdes AM, De Wilde G, Doherty SA, Lories RJ, Vaughn FL, Laslett LL, Maciewicz RA, Soni A, Hart DJ, Zhang W. The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis. Ann Rheum Dis 2011, 70:1556-1561. 10.1136/ard.2010.148122, 3147243, 21616913.
17. Robertson J, Zhang W, Liu JJ, Muir KR, Maciewicz RA, Doherty M. Radiographic assessment of the index to ring finger ratio (2D:4D) in adults. J Anat 2008, 212:42-48. 2423386, 18005121.
18. Peach CA, Zhang Y, Dunford JE, Brown MA, Carr AJ. Cuff tear arthropathy: evidence of functional variation in pyrophosphate metabolism genes. Clin Orthop Relat Res 2007, 462:67-72.
19. Vistoropsky Y, Keter M, Malkin I, Trofimov S, Kobyliansky E, Livshits G. Contribution of the putative genetic factors and ANKH gene polymorphisms to variation of circulating calciotropic molecules, PTH and BGP. Hum Mol Genet 2007, 16:1233-1240. 10.1093/hmg/ddm071, 17403715.
20. Alizadeh BZ, Njajou OT, Hazes JM, Hofman A, Slagboom PE, Pols HA, van Duijn CM. The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis. Ann Rheum Dis 2007, 66:1436-1442. 10.1136/ard.2006.063099, 2111641, 17284543.
21. Timms AE, Sathananthan R, Bradbury L, Athanasou NA, Wordsworth BP, Brown MA. Genetic testing for haemochromatosis in patients with chondrocalcinosis. Ann Rheum Dis 2002, 61:745-747. 10.1136/ard.61.8.745, 1754204, 12117686.
22. Goseki-Sone M, Sogabe N, Fukushi-Irie M, Mizoi L, Orimo H, Suzuki T, Nakamura H, Orimo H, Hosoi T. Functional analysis of the single nucleotide polymorphism (787T>C) in the tissue-nonspecific alkaline phosphatase gene associated with BMD. J Bone Miner Res 2005, 20:773-782.
23. Suk EK, Malkin I, Dahm S, Kalichman L, Ruf N, Kobyliansky E, Toliat M, Rutsch F, Nürnberg P, Livshits G. Association of ENPP1 gene polymorphisms with hand osteoarthritis in a Chuvasha population. Arthritis Res Ther 2005, 7:R1082-R1090. 10.1186/ar1786, 1257435, 16207325.
24. Valli-Jaakola K, Suviolahti E, Schalin-Jäntti C, Ripatti S, Silander K, Oksanen L, Salomaa V, Peltonen L, Kontula K. Further evidence for the role of ENPP1 in obesity: association with morbid obesity in Finns. Obesity (Silver Spring) 2008, 16:2113-2119. 10.1038/oby.2008.313, 18551113.
25. Benyamin B, McRae AF, Zhu G, Gordon S, Henders AK, Palotie A, Peltonen L, Martin NG, Montgomery GW, Whitfield JB, Visscher PM. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am J Hum Genet 2009, 84:60-65. 10.1016/j.ajhg.2008.11.011, 2668053, 19084217.
26. R Development Core Team R: A Language and Environment for Statistical Computing 2010, Vienna, Austria: R Foundation for Statistical Computing, Retrieved from http://www.R-project.org, R Development Core Team.
27. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
28. Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL, de Mazancourt P, Mornet E. Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet 2009, 10:51. 2702372, 19500388.
29. Zhang Y, Brown MA, Peach C, Russell G, Wordsworth BP. Investigation of the role of ENPP1 and TNAP genes in chondrocalcinosis. Rheumatology (Oxford) 2007, 46:586-589.
30. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000, 289:265-270. 10.1126/science.289.5477.265, 10894769.
31. Gurley KA, Reimer RJ, Kingsley DM. Biochemical and genetic analysis of ANK in arthritis and bone disease. Am J Hum Genet 2006, 79:1017-1029. 10.1086/509881, 1698704, 17186460.
32. Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M, Dixey J, Gillet P, Loeuille D, McGrath R, Reginato A, Shiang R, Wright G, Netter P, Williams C, Kingsley DM. Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet 2002, 71:933-940. 10.1086/343054, 378546, 12297987.